Abstract
Central nervous system toxicity associated with chemotherapeutic agents has been reported in the past. Many potentially promising chemotherapeutic agents are unusable because of central nervous system toxicity. We report a case of neurological complications observed in a subject with a retroperitoneal fibromyxosarcoma treated with Adriamycin and Vincristine. The neurological symptoms started an hour after drug administration and rapidly declined with appropriate therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.